Effects of Telbivudine Treatment on the Circulating CD4<sup>+</sup> T-Cell Subpopulations in Chronic Hepatitis B Patients

<table>Clinical characteristics of CHB patients after treatment with telbivudine. Serum samples were collected from 38 CHB patients treated with telbivudine at five time points after treatment initiation. HBV DNA level was detected by qPCR. Serum HBsAg concentration was detected by ELISA. Serum ALT was measured by the CHEMIX-180 automated biochemistry analyzer (Japanese SYSMEX Corporation). ***<svg height="11.375" id="M6" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 66.875 11.375" width="66.875" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,58.64,11.112)"><use xlink:href="#x31"></use></g>
</svg>   versus  baseline (0).</table>

Mediators of Inflammation

fig1

Figure 1

Figure 1: Effects of Telbivudine Treatment on the Circulating CD4<sup>+</sup> T-Cell Subpopulations in Chronic Hepatitis B Patients 

Mediators of Inflammation

Effects of Telbivudine Treatment on the Circulating CD4+ T-Cell Subpopulations in Chronic Hepatitis B Patients

Figure 1

Effects of Telbivudine Treatment on the Circulating CD4⁺ T-Cell Subpopulations in Chronic Hepatitis B Patients